We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

7 hedge funds and large institutions have $845K invested in Alexion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 693 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 707 → 7 (-700)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 693

100% less funds holding in top 10

Funds holding in top 10: 77 → 0 (-77)

100% less capital invested

Capital invested by funds: $38.8B → $845K (-$38.8B)

Holders
7
Holders Change
-700
Holders Change %
-99.01%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-77
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
693
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NICM
Neo Ivy Capital Management
New York
+$475K
2
TAIM
TD Ameritrade Investment Management
Nebraska
+$131K
3
RG
Retirement Group
California
+$9.37K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74B
2
BlackRock
BlackRock
New York
-$3.21B
3
State Street
State Street
Massachusetts
-$1.84B
4
FCM
Farallon Capital Management
California
-$1.42B
5
HI
HBK Investments
Texas
-$1.21B
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
351
LPL Financial
California
– -$2.13M -11,619 Closed
Man Group
352
Man Group
United Kingdom
– -$2.13M -11,600 Closed
MC
353
Maverick Capital
Texas
– -$2.1M -11,420 Closed
M&T Bank
354
M&T Bank
New York
– -$2.1M -11,415 Closed
VCM
355
Vigilant Capital Management
Maine
– -$2.08M -11,321 Closed
FC
356
FCA Corp
Texas
– -$2.02M -11,022 Closed
EOJOAM
357
E. Ohman J:or Asset Management
Sweden
– -$1.93M -10,500 Closed
SDIC
358
South Dakota Investment Council
South Dakota
– -$1.9M -10,358 Closed
GT
359
Glenmede Trust
Pennsylvania
– -$1.88M -10,236 Closed
Osaic Holdings
360
Osaic Holdings
Arizona
– -$1.86M -10,157 Closed
NMIMC
361
Northwestern Mutual Investment Management Company
Wisconsin
– -$1.84M -10,037 Closed
Commonwealth Equity Services
362
Commonwealth Equity Services
Massachusetts
– -$1.84M -10,019 Closed
Connor, Clark & Lunn Investment Management (CC&L)
363
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.81M -9,842 Closed
S
364
Seeyond
France
– -$1.75M -9,538 Closed
Thrivent Financial for Lutherans
365
Thrivent Financial for Lutherans
Minnesota
– -$1.74M -9,493 Closed
LIM
366
Leavell Investment Management
Alabama
– -$1.44M -9,401 Closed
TRCT
367
Tower Research Capital (TRC)
New York
– -$1.72M -9,367 Closed
JMPWA
368
JP Morgan Private Wealth Advisors
California
– -$1.72M -9,360 Closed
DILIC
369
Dai-ichi Life Insurance Company
Japan
– -$1.7M -9,256 Closed
DTL
370
Dynamic Technology Lab
Singapore
– -$1.69M -9,184 Closed
LFAS
371
Level Four Advisory Services
Texas
– -$1.67M -9,064 Closed
NSEDCP
372
NJ State Employees Deferred Compensation Plan
New Jersey
– -$1.65M -9,000 Closed
Kovitz Investment Group Partners
373
Kovitz Investment Group Partners
Illinois
– -$1.65M -8,979 Closed
SEC
374
Seven Eight Capital
New York
– -$1.61M -8,793 Closed
SAM
375
Shell Asset Management
Netherlands
– -$1.6M -8,706 Closed
13 14
15
16 17

ALXN Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2021, worth a combined $845K — down 100% from $38.8B a quarter earlier.

Sellers outnumbered buyers: 693 funds closed out of ALXN and 1 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Neo Ivy Capital Management, opening a new position worth an estimated $475K. The largest seller was Vanguard Group, exiting entirely with an estimated $3.74B sold.

  • 7 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q3 2021, down from 707 in Q2 2021.
  • Funds reported $845K of Alexion Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Alexion Pharmaceuticals positions in Q3 2021 and 693 closed out, a net change of -692 holders.
  • The largest Alexion Pharmaceuticals buyer in Q3 2021 was Neo Ivy Capital Management, an estimated $475K added.
  • The largest Alexion Pharmaceuticals seller in Q3 2021 was Vanguard Group, an estimated $3.74B sold.

Based on aggregated 13F filings for Q3 2021.